Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 01, 2023

Vorinostat for the Treatment of Germline Missense VHL Disease

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Proteostasis modulation in germline missense von Hippel Lindau disease
Clin. Cancer Res 2023 Apr 05;[EPub Ahead of Print], P Chittiboina, D Mandal, A Bugarini, DT Asuzu, D Mullaney, P Mastorakos, S Stoica, R Alvarez, G Scott, D Maric, A Elkahloun, Z Zhuang, EY Chew, C Yang, M Linehan, RR Lonser

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading